Purpose
Acinetobacter baumannii
(
A. baumannii
or AB) is one of the most opportunistic, nosocomial pathogens threatening public healthcare across countries.
A. baumannii
has become a primary growing concern due to its exceptional ability to acquire antimicrobial resistance (AMR) to multiple antimicrobial agents which is increasingly reported and more prevalent every year. Therefore, there is an urgent need to evaluate the AMR knowledge of
A. baumannii
for effective clinical treatment of nosocomial infections. This study aimed to investigate the clinical distribution AMR phenotypes and genotypes, and genomic characteristics of
A. baumannii
isolates recovered from hospitalized patients of different clinical departments of a sentinel hospital to improve clinical practices.
Methods
A total of 123 clinical isolates were recovered from hospitalized patients of different clinical departments during 2019–2021 to analyze AMR patterns, and further subjected to whole-genome sequencing (WGS) investigations. Multi-locus sequence typing (MLST), as well as the presence of antimicrobial-resistant genes (ARGs), virulence factor genes (VFGs) and insertion sequences (ISs) were also investigated from WGS data.
Results
The results highlighted that
A. baumannii
clinical isolates had shown a high AMR rate, particularly from the intensive care unit (ICU), towards routinely used antimicrobials, ie, β-lactams and fluoroquinolones. ST2 was the most prevalent ST in the clinical isolates, it was strongly associated to the resistance of cephalosporins and carbapenems, with
bla
OXA-23
and
bla
OXA-66
being the most frequent determinants; moreover, high carrier rate of VFGs was also observed such as all strains containing the
ompA, adeF, pgaC, lpsB
, and
bfmR
genes.
Conclusion
Acinetobacter baumannii
clinical isolates are mostly ST2 with high rates of drug resistance and carrier of virulence factors. Therefore, it requires measurements to control its transmission and infection.